Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources
- PMID: 2386978
- PMCID: PMC11038414
- DOI: 10.1007/BF01741403
Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources
Abstract
Four cell-mediated immunological responses related to tumor elimination have been examined in mice injected with a transplantable renal cell carcinoma (Renca). Lymphokine-activated killer (LAK) cells generated in vitro from spleen cells of normal mice were capable of attacking Renca, EL-4, P815 and YAC-1 targets, but those from mice bearing Renca for 3 weeks could not. Natural killer activity, stimulated in vivo by administering poly(I) poly(C), was less than 50% of normal in Renca-bearing hosts. In addition, development of cytotoxic T lymphocytes to allogeneic targets was markedly inhibited in mice possessing the renal tumor. Finally, the delayed hypersensitivity response to a dermally applied hapten was approximately 70% less than normal in tumor-bearing mice, no matter whether the tumor existed subcutaneously or intrarenally. A kinetic study of the development of non-responsiveness using the LAK assay showed onset of poor response at 1 week, which became maximal within 3 weeks following receipt of tumor subcutaneously. The immunological depression was seen to be attributable in part to suppressor cells present among spleen cells but not bone marrow cells of tumor-bearing hosts. The suppressor cells prevented in vitro LAK generation by normal spleen cells and, when adoptively transferred to normal mice, they inhibited natural killer stimulation and delayed hypersensitivity generation. Another source of immunological down-regulation was provided by Renca cells themselves. Incorporation of Renca cells that had been X-irradiated with 30,000 rad into cultures of normal and Renca-derived splenic cells suppressed replication of both almost completely. Furthermore, the presence of X-irradiated Renca cells in cultures of normal spleen cells prevented development of LAK cells. Thus, the suppression seen in Renca-bearing mice derives from multiple sources and whether each is in any way related to the other has been discussed. Identification of the phenotypes of cells responsible for the lymphoid cell-mediated suppression and examination of its elimination are communicated in the companion paper.
Similar articles
-
Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.Cancer Immunol Immunother. 1990;31(6):335-41. doi: 10.1007/BF01741404. Cancer Immunol Immunother. 1990. PMID: 1974826 Free PMC article.
-
Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.J Urol. 2007 Oct;178(4 Pt 1):1504-9. doi: 10.1016/j.juro.2007.05.115. Epub 2007 Aug 16. J Urol. 2007. PMID: 17707061
-
Improved lymphocyte cytotoxicity against murine renal cell carcinoma.J Urol. 1992 Feb;147(2):491-5. doi: 10.1016/s0022-5347(17)37286-5. J Urol. 1992. PMID: 1732630
-
Neutralization of interleukin-2 retards the growth of mouse renal cancer.BJU Int. 2006 Jun;97(6):1314-21. doi: 10.1111/j.1464-410X.2006.06180.x. BJU Int. 2006. PMID: 16686731
-
Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.Expert Opin Biol Ther. 2011 Dec;11(12):1555-67. doi: 10.1517/14712598.2011.627852. Epub 2011 Oct 14. Expert Opin Biol Ther. 2011. PMID: 21995459 Review.
Cited by
-
Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.Cancer Immunol Immunother. 1990;31(6):335-41. doi: 10.1007/BF01741404. Cancer Immunol Immunother. 1990. PMID: 1974826 Free PMC article.
-
T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.J Exp Med. 1995 Oct 1;182(4):1029-36. doi: 10.1084/jem.182.4.1029. J Exp Med. 1995. PMID: 7561676 Free PMC article.
-
DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.Cancer Immunol Immunother. 2007 Nov;56(11):1817-29. doi: 10.1007/s00262-007-0325-0. Epub 2007 Apr 19. Cancer Immunol Immunother. 2007. PMID: 17443323 Free PMC article.
References
-
- Asherson GL, Zembala M. The role of T acceptor cell in suppressor systems: antigen specific T suppressor factor acts via a T acceptor cell; this releases a non-specific inhibitor of the transfer of contact sensitivity when exposed to antigen in the context of I-J. Ann NY Acad Sci. 1982;392:71–71. - PubMed
-
- Bassil B, Dosoretz DE, Prout GR., Jr Validation of the tumor, nodes and metastasis classification of renal cell carcinoma. J Urol. 1985;134:450–450. - PubMed
-
- Bear HD. Tumor-specific T-cells which inhibit thein vitro generation of cytolytic T-cells from immune and early tumor bearing host spleens. Cancer Res. 1986;46:1805–1805. - PubMed
-
- Bear HD, Susskind BM, Close KA, Barrett SK. Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for theirin vitro generation from tumor-bearing host and immune spleens. Cancer Res. 1988;48:1422–1422. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical